Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 2008, InCube Ventures, LLC operates from Silicon Valley and San Antonio, managing multiple funds including DFJ InCube Ventures in partnership with Draper Fisher Jurvetson. The firm focuses on life sciences, specifically targeting companies that address significant clinical needs for large patient populations. InCube Ventures serves as the venture arm of InCube Labs, a dedicated research and development lab.
InCube Ventures specializes in early to late-stage investments in pharmaceuticals, biologics, and medical devices. The firm typically invests across pre-seed to Series C stages, emphasizing companies that can significantly enhance patient outcomes and establish new standards of care. Their investment strategy prioritizes breakthrough innovations over incremental improvements.
Notable portfolio companies include Metagenomi, developing gene editing systems; WhiteSwell, innovating treatments for heart failure; and Neuros Medical, pioneering neuromodulation therapy for chronic pain. Other significant investments include Nfocus (acquired by Covidien), Sonoma Orthopedics (acquired by Arthrex), and Spinal Modulation (acquired by St. Jude Medical).
To pitch InCube Ventures, email your deck to info@incubeventures.com.
InCube Ventures focuses on life sciences companies that address unmet clinical needs, investing in pharmaceuticals, biologics, and medical devices.
Yes, InCube Ventures often leads investment rounds, particularly in early-stage life sciences companies.
The firm invests across various stages, with check sizes typically ranging from pre-seed to Series C funding rounds.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.